Literature DB >> 28010942

Syndrome of inappropriate antidiuretic hormone secretion in a case of olfactory neuroblastoma without anti-diuretic hormone immunoreactivity: A case report and review of the literature.

Takafumi Nakano1, Junichi Motoshita2, Fumi Sawada3, Midori Okabe4, Akihiro Tamae4, Shinsuke Hiramatsu3, Satoru Kodama5, Hideki Shiratsuchi4, Ryuji Yasumatsu6, Torahiko Nakashima6, Takashi Nakagawa6.   

Abstract

Olfactory neuroblastoma (ONB) is a relatively rare nasal or paranasal malignant tumor. This tumor is rarely accompanied by paraneoplastic syndromes such as syndrome of inappropriate antidiuretic hormone secretion (SIADH). Here, we report a 31-year-old female with histologically confirmed ONB who had been diagnosed with SIADH three years prior. She was treated with surgery followed by concurrent chemoradiotherapy. SIADH resolved immediately after surgical tumor resection. Immunohistochemically, both biopsy and resected specimens from the nasal cavity had been negative for ADH. Although extremely rare, ONB may be associated with SIADH, and the possibility of this cancer should be taken into account during the follow-up of idiopathic SIADH.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-diuretic hormone; Olfactory neuroblastoma; Syndrome of inappropriate antidiuretic hormone secretion

Mesh:

Substances:

Year:  2016        PMID: 28010942     DOI: 10.1016/j.anl.2016.11.012

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  4 in total

Review 1.  Exclusively endoscopic surgical resection of esthesioneuroblastoma: A systematic review.

Authors:  Daniel B Spielman; Andi Liebowitz; Maeher Grewal; Chetan Safi; Jonathan B Overdevest; Alfred M Iloreta; Brett E Youngerman; David A Gudis
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-03-22

2.  A sellar neuroblastoma showing rapid growth and causing syndrome of inappropriate secretion of antidiuretic hormone: A case report.

Authors:  Muhammad Kamil; Nayuta Higa; Hajime Yonezawa; Shingo Fujio; Jun Sugata; Tomoko Takajo; Tsubasa Hiraki; Junko Hirato; Kazunori Arita; Koji Yoshimoto
Journal:  Surg Neurol Int       Date:  2020-06-27

3.  The V2 receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells.

Authors:  G Marroncini; C Anceschi; L Naldi; B Fibbi; F Baldanzi; M Maggi; A Peri
Journal:  J Endocrinol Invest       Date:  2022-05-23       Impact factor: 5.467

Review 4.  Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment.

Authors:  Mario Turri-Zanoni; Giacomo Gravante; Paolo Castelnuovo
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.